BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

537 related articles for article (PubMed ID: 33220695)

  • 41. High-dose methylprednisolone in nonintubated patients with severe COVID-19 pneumonia.
    Papamanoli A; Yoo J; Grewal P; Predun W; Hotelling J; Jacob R; Mojahedi A; Skopicki HA; Mansour M; Marcos LA; Kalogeropoulos AP
    Eur J Clin Invest; 2021 Feb; 51(2):e13458. PubMed ID: 33219551
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Risk Factors Associated With In-Hospital Mortality in a US National Sample of Patients With COVID-19.
    Rosenthal N; Cao Z; Gundrum J; Sianis J; Safo S
    JAMA Netw Open; 2020 Dec; 3(12):e2029058. PubMed ID: 33301018
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mortality and critical care unit admission associated with the SARS-CoV-2 lineage B.1.1.7 in England: an observational cohort study.
    Patone M; Thomas K; Hatch R; Tan PS; Coupland C; Liao W; Mouncey P; Harrison D; Rowan K; Horby P; Watkinson P; Hippisley-Cox J
    Lancet Infect Dis; 2021 Nov; 21(11):1518-1528. PubMed ID: 34171232
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association Between Upper Respiratory Tract Viral Load, Comorbidities, Disease Severity, and Outcome of Patients With SARS-CoV-2 Infection.
    Maltezou HC; Raftopoulos V; Vorou R; Papadima K; Mellou K; Spanakis N; Kossyvakis A; Gioula G; Exindari M; Froukala E; Martinez-Gonzalez B; Panayiotakopoulos G; Papa A; Mentis A; Tsakris A
    J Infect Dis; 2021 Apr; 223(7):1132-1138. PubMed ID: 33388780
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of Hydroxychloroquine on Covid-19 in Intensive Care Unit Patients: Preliminary Results.
    Lopez A; Duclos G; Pastene B; Bezulier K; Guilhaumou R; Solas C; Zieleskiewicz L; Leone M
    Int J Antimicrob Agents; 2020 Nov; 56(5):106136. PubMed ID: 32777263
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maternal and Neonatal Outcomes of Critically Ill Pregnant and Puerperal Patients Diagnosed with COVID-19 Disease: Retrospective Comparative Study.
    Eman A; Balaban O; Kocayiğit H; Süner KÖ; Cırdı Y; Erdem AF
    J Korean Med Sci; 2021 Nov; 36(44):e309. PubMed ID: 34783218
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Temporal trends of COVID-19 related in-hospital mortality and demographics in Switzerland - a retrospective single centre cohort study.
    Diebold M; Martinez AE; Adam KM; Bassetti S; Osthoff M; Kassi E; Steiger J; Pargger H; Siegemund M; Battegay M; Khanna N; Schaub S; Wesch C; Dickenmann M; Weisser M
    Swiss Med Wkly; 2021 Jul; 151():w20572. PubMed ID: 34324697
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the effect of melatonin in patients with COVID-19-induced pneumonia admitted to the Intensive Care Unit: A structured summary of a study protocol for a randomized controlled trial.
    Ameri A; Asadi MF; Kamali M; Vatankhah M; Ziaei A; Safa O; Mahmudi M; Fathalipour M
    Trials; 2021 Mar; 22(1):194. PubMed ID: 33685474
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Coagulopathy of hospitalised COVID-19: A Pragmatic Randomised Controlled Trial of Therapeutic Anticoagulation versus Standard Care as a Rapid Response to the COVID-19 Pandemic (RAPID COVID COAG - RAPID Trial): A structured summary of a study protocol for a randomised controlled trial.
    Sholzberg M; Tang GH; Negri E; Rahhal H; Kreuziger LB; Pompilio CE; James P; Fralick M; AlHamzah M; Alomran F; Tseng E; Lim G; Lillicrap D; Carrier M; Áinle FN; Beckett A; da Costa BR; Thorpe K; Middeldorp S; Lee A; Cushman M; Jüni P
    Trials; 2021 Mar; 22(1):202. PubMed ID: 33691765
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical and therapeutic outcomes of COVID-19 intensive care units (ICU) patients: a retrospective study in Ghana.
    Afriyie-Mensah J; Aboagye ET; Ganu VJ; Bondzi S; Tetteh D; Kwarteng E; Akamah J; Doku A; Adjei P
    Pan Afr Med J; 2021; 38():107. PubMed ID: 33912277
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A comparison of clinical, laboratory and chest CT findings of laboratory-confirmed and clinically diagnosed COVID-19 patients at first admission.
    Kuzan TY; Murzoğlu Altıntoprak K; Çiftçi HÖ; Ergül U; Ünal Özdemir NB; Bulut M; Yiyit N
    Diagn Interv Radiol; 2021 May; 27(3):336-343. PubMed ID: 32876570
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characteristics and Outcomes Based on Perceived Illness Severity in SARS-CoV-2.
    Snipelisky D; Johnson R; Prasad R; Lakhani B; Ellington J
    South Med J; 2020 Dec; 113(12):618-622. PubMed ID: 33263129
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Distinct Outcomes in COVID-19 Patients with Positive or Negative RT-PCR Test.
    Saad Menezes MC; Santinelli Pestana DV; Ferreira JC; Ribeiro de Carvalho CR; Felix MC; Marcilio IO; da Silva KR; Junior VC; Marchini JF; Alencar JC; Gomez LMG; Mauá DD; Souza HP; Emergency Usp Covid-Group ; Hcfmusp Covid-Study Group
    Viruses; 2022 Jan; 14(2):. PubMed ID: 35215772
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of clinical, para-clinical and laboratory findings in survived and deceased patients with COVID-19: diagnostic role of inflammatory indications in determining the severity of illness.
    Rokni M; Ahmadikia K; Asghari S; Mashaei S; Hassanali F
    BMC Infect Dis; 2020 Nov; 20(1):869. PubMed ID: 33225909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk factors associated with intensive care unit (ICU) admission and in-hospital death among adults hospitalized with COVID-19: a two-center retrospective observational study in tertiary care hospitals.
    Shayganfar A; Sami R; Sadeghi S; Dehghan M; Khademi N; Rikhtehgaran R; Basiratnia R; Ferdosi F; Hajiahmadi S
    Emerg Radiol; 2021 Aug; 28(4):691-697. PubMed ID: 33534017
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Association of Remdesivir Treatment With Survival and Length of Hospital Stay Among US Veterans Hospitalized With COVID-19.
    Ohl ME; Miller DR; Lund BC; Kobayashi T; Richardson Miell K; Beck BF; Alexander B; Crothers K; Vaughan Sarrazin MS
    JAMA Netw Open; 2021 Jul; 4(7):e2114741. PubMed ID: 34264329
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predictors of Severity in Covid-19 Patients in Casablanca, Morocco.
    El Aidaoui K; Haoudar A; Khalis M; Kantri A; Ziati J; El Ghanmi A; Bennis G; El Yamani K; Dini N; El Kettani C
    Cureus; 2020 Sep; 12(9):e10716. PubMed ID: 33033687
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Infliximab and Intravenous Gammaglobulin in Hospitalized Severe COVID-19 Patients in Intensive Care Unit.
    Farrokhpour M; Rezaie N; Moradi N; Ghaffari Rad F; Izadi S; Azimi M; Zamani F; Izadi S; Ranjbar M; Jamshidi Makiani M; Laali A; Roham M; Yadollahzadeh M
    Arch Iran Med; 2021 Feb; 24(2):139-143. PubMed ID: 33636983
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute kidney injury: Incidence, risk factors, and outcomes in severe COVID-19 patients.
    de Almeida DC; Franco MDCP; Dos Santos DRP; Santos MC; Maltoni IS; Mascotte F; de Souza AA; Pietrobom PM; Medeiros EA; Ferreira PRA; Machado FR; Goes MA
    PLoS One; 2021; 16(5):e0251048. PubMed ID: 34033655
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.